Gelsolin negatively regulates the activity of tumor suppressor p53 through their physical interaction in hepatocarcinoma HepG2 cells

Biochemical and Biophysical Research Communications

Volumn 412, Issue 1, 2011, Pages 44-49

  An, Joo Hee ^a   Kim, Jung Woong ^a   Jang, Sang Min ^a   Kim, Chul Hong ^a   Kang, Eun Jin ^a   Choi, Kyung Hee ^a  

^a Chung Ang University   (South Korea)

Author keywords

Apoptosis; Gelsolin; Hepatocarcinoma; P53; Protein protein interaction; Transcriptional regulation

Indexed keywords

DNA BINDING PROTEIN; GELSOLIN; PROTEIN P53; REGULATOR PROTEIN;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE REGULATION; CELL NUCLEUS; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOPLASM; GENE CONSTRUCT; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REPORTER CONSTRUCT; TRANSCRIPTION REGULATION;

ACTINS; ACTIVE TRANSPORT, CELL NUCLEUS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL NUCLEUS; GELSOLIN; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80051791020     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.07.034     Document Type: Article

References (36)

1. Ryan K.M., Phillips A.C., Vousden K.H. Regulation and function of the p53 tumor suppressor protein. Current Opinion in Cell Biology 2001, 13:332-337.
2. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
3. Harris C.C., Hollstein M. Clinical implications of the p53 tumor-suppressor gene. New England Journal of Medicine 1993, 329:1318-1327.
4. Barak Y., Juven T., Haffner R., Oren M. mdm2 expression is induced by wild type p53 activity. EMBO Journal 1993, 12:461-468.
5. Nakano K., Vousden K.H., PUMA A novel proapoptotic gene is induced by p53. Molecular Cell 2001, 7:683-694.
6. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell 1995, 80:293-299.
7. el-Deiry W.S., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E., Jackman J., Pietenpol J.A., Burrell M., Hill D.E., Wang Y., et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Research 1994, 54:1169-1174.
8. Bosari S., Viale G., Roncalli M., Graziani D., Borsani G., Lee A.K., Coggi G. p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. American Journal of Pathology 1995, 147:790-798.
9. Moll U.M., Riou G., Levine A.J. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proceedings of the National Academy of Sciences USA 1992, 89:7262-7266.
10. Wadhwa R., Yaguchi T., Hasan M.K., Mitsui Y., Reddel R.R., Kaul S.C. Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein. Experimental Cell Research 2002, 274:246-253.
11. Wadhwa R., Takano S., Robert M., Yoshida A., Nomura H., Reddel R.R., Mitsui Y., Kaul S.C. Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member. Journal of Biological Chemistry 1998, 273:29586-29591.
12. Ryan J.J., Prochownik E., Gottlieb C.A., Apel I.J., Merino R., Nunez G., Clarke M.F. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proceedings of the National Academy of Sciences USA 1994, 91:5878-5882.
13. Lee S.Y., Kim J.W., Jeong M.H., An J.H., Jang S.M., Song K.H., Choi K.H. Microtubule-associated protein 1B light chain (MAP1B-LC1) negatively regulates the activity of tumor suppressor p53 in neuroblastoma cells. FEBS Letters 2008, 582:2826-2832.
14. Kwiatkowski D.J. Functions of gelsolin: motility, signaling, apoptosis, cancer. Current Opinion in Cell Biology 1999, 11:103-108.
15. Moriya S., Yanagihara K., Fujita H., Kuzumaki N. Differential expression of hsp90 gelsolin and gst-pi in human gastric-carcinoma cell-lines. International Journal of Oncology 1994, 5:1347-1351.
16. Mullauer L., Fujita H., Ishizaki A., Kuzumaki N. Tumor-suppressive function of mutated gelsolin in ras-transformed cells. Oncogene 1993, 8:2531-2536.
17. Tanaka H., Shirkoohi R., Nakagawa K., Qiao H., Fujita H., Okada F., Hamada J., Kuzumaki S., Takimoto M., Kuzumaki N. siRNA gelsolin knockdown induces epithelial-mesenchymal transition with a cadherin switch in human mammary epithelial cells. International Journal of Cancer 2006, 118:1680-1691.
18. Kothakota S., Azuma T., Reinhard C., Klippel A., Tang J., Chu K., McGarry T.J., Kirschner M.W., Koths K., Kwiatkowski D.J., Williams L.T. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997, 278:294-298.
19. Azuma T., Koths K., Flanagan L., Kwiatkowski D. Gelsolin in complex with phosphatidylinositol 4, 5-bisphosphate inhibits caspase-3 and -9 to retard apoptotic progression. Journal of Biological Chemistry 2000, 275:3761-3766.
20. Kusano H., Shimizu S., Koya R.C., Fujita H., Kamada S., Kuzumaki N., Tsujimoto Y. Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial changes via closing VDAC. Oncogene 2000, 19:4807-4814.
21. Rao J., Seligson D., Visapaa H., Horvath S., Eeva M., Michel K., Pantuck A., Belldegrun A., Palotie A. Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma. Cancer 2002, 95:1247-1257.
22. Shieh D.B., Godleski J., Herndon J.E., Azuma T., Mercer H., Sugarbaker D.J., Kwiatkowski D.J. Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma: the role of gelsolin expression. Cancer 1999, 85:47-57.
23. Lee Y.H., Campbell H.D., Stallcup M.R. Developmentally essential protein flightless I is a nuclear receptor coactivator with actin binding activity. Molecular and Cellular Biology 2004, 24:2103-2117.
24. Sampson E.R., Yeh S.Y., Chang H.C., Tsai M.Y., Wang X., Ting H.J., Chang C. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells. Journal of Biological Regulators and Homeostatic Agents 2001, 15:123-129.
25. Ting H.J., Yeh S., Nishimura K., Chang C. Supervillin associates with androgen receptor and modulates its transcriptional activity. Proceedings of the National Academy of Sciences USA 2002, 99:661-666.
26. Nishimura K., Ting H.J., Harada Y., Tokizane T., Nonomura N., Kang H.Y., Chang H.C., Yeh S., Miyamoto H., Shin M., Aozasa K., Okuyama A., Chang C. Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer Research 2003, 63:4888-4894.
27. Kim C.S., Furuya F., Ying H., Kato Y., Hanover J.A., Cheng S.Y. Gelsolin: a novel thyroid hormone receptor-beta interacting protein that modulates tumor progression in a mouse model of follicular thyroid cancer. Endocrinology 2007, 148:1306-1312.
28. Jeong M.H., Bae J., Kim W.H., Yoo S.M., Kim J.W., Song P.I., Choi K.H. p19ras interacts with and activates p73 by involving the MDM2 protein. Journal of Biological Chemistry 2006, 281:8707-8715.
29. Kim K.C., Kim T.S., Kang K.H., Choi K.H. Amphiphysin IIb-1 a novel splicing variant of amphiphysin II regulates p73beta function through protein-protein interactions. Oncogene 2001, 20:6689-6699.
30. David-Pfeuty T., Chakrani F., Ory K., Nouvian-Dooghe Y. Cell cycle-dependent regulation of nuclear p53 traffic occurs in one subclass of human tumor cells and in untransformed cells. Cell Growth and Differentiation 1996, 7:1211-1225.
31. Trostel S.Y., Sackett D.L., Fojo T. Oligomerization of p53 precedes its association with dynein and nuclear accumulation. Cell Cycle 2006, 5:2253-2259.
32. Giannakakou P., Sackett D.L., Ward Y., Webster K.R., Blagosklonny M.V., Fojo T. p53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nature Cell Biology 2000, 2:709-717.
33. Liu S., Li J., Tao Y., Xiao X. Small heat shock protein alphaB-crystallin binds to p53 to sequester its translocation to mitochondria during hydrogen peroxide-induced apoptosis. Biochemical and Biophysical Research Communications 2007, 354:109-114.
34. Lu W.J., Lee N.P., Kaul S.C., Lan F., Poon R.T., Wadhwa R., Luk J.M. Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin. International Journal of Cancer 2010.
35. Nikolaev A.Y., Li M., Puskas N., Qin J., Gu W. Parc: a cytoplasmic anchor for p53. Cell 2003, 112:29-40.
36. Zhao L.Y., Liao D. Sequestration of p53 in the cytoplasm by adenovirus type 12 E1B 55-kilodalton oncoprotein is required for inhibition of p53-mediated apoptosis. Journal of Virology 2003, 77:13171-13181.